Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 5/20 | 0.57 |
| ▸ | PGR | P06401 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | HRH1 | P35367 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | AR | P10275 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Homosalate SCHEMBL2016281 | 0.87 | LMNA (0.86) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 | |
| Homosalate SCHEMBL2808104 | 0.84 | ALDH1A1 (0.97) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 | |
| Homosalate SCHEMBL8106557 | 0.83 | LMNA (0.86) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 | |
| Homosalate SCHEMBL8840156 | 0.83 | ALDH1A1 (0.86) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 | |
| Homosalate SCHEMBL3634890 | 0.82 | ALDH1A1 (1.00) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 | |
| Homosalate SCHEMBL16207 | 0.82 | ALDH1A1 (1.00) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 | |
| Homosalate SCHEMBL29356436 | 0.82 | ALDH1A1 (1.00) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 | |
| Homosalate SCHEMBL8863191 | 0.82 | LMNA (0.84) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 | |
| Oxybenzone SCHEMBL28230340 | 0.79 | HPGD (0.91) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 | |
| Dioxybenzone SCHEMBL5161579 | 0.78 | HPGD (0.88) | LMNAALDH1A1CYP1A2CYP2C19CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012000674-A1 | TOPICAL COMPOSITION FOR THE TREATMENT OF SCAR TISSUE | SYLPHAR (BE) | 2012-01-05 | — | — | WO | claimed |
| WO-2024102219-A1 | COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER | XMK THERAPEUTICS INC. (CA) | 2024-05-16 | — | — | WO | disclosed |
| US-10743604-B2 | Articles of manufacture releasing an active ingredient | NNTT TECH INC. (CA) | 2020-08-18 | — | — | US | disclosed |
| EP-3434264-A1 | MICROPARTICLE FOR RELEASING AN ACITVE AGENT | Biomod Concepts Inc. (CA) | 2019-01-30 | — | — | EP | disclosed |
| EP-2317984-B1 | ARTICLES OF MANUFACTURE RELEASING AN ACTIVE INGREDIENT | BIOMOD CONCEPTS INC (CA) | 2018-10-31 | — | — | EP | disclosed |
| US-20180146735-A1 | Articles Of Manufacture Releasing An Active Ingredient | NNTT TECH INC. (CA) | 2018-05-31 | — | — | US | disclosed |
| US-9883710-B2 | Articles of manufacture releasing an active ingredient | BIOMOD CONCEPTS INC. (CA) | 2018-02-06 | — | — | US | disclosed |
| US-9861154-B2 | Articles of manufacture releasing an active ingredient | BIOMOD COLLECTION INC. (CA) | 2018-01-09 | — | — | US | disclosed |
| US-9730483-B2 | Articles of manufacture releasing an active ingredient | BIOMOD CONCEPTS INC. (CA) | 2017-08-15 | — | — | US | disclosed |
| CN-102099015-B | Articles of manufacture releasing an active ingredient | BIOMOD CONCEPTS INC | 2015-05-06 | — | — | CN | disclosed |
| US-20030232094-A1 | Composition and method for the treatment of skin irritations | FULLER PETER E (US) | 2003-12-18 | — | — | US | disclosed |
| EP-1251818-A1 | GALENIC FORMULATION | MERCK PATENT GmbH (DE) | 2002-10-30 | — | — | EP | disclosed |
| CN-1353735-A | Silicone gel containing salicylic acid | NEUTROGENA CORP (US) | 2002-06-12 | — | — | CN | disclosed |
| US-6384023-B2 | SKIN DISORDERS; ACNE, SEBORRHEA | NEUTROGENA CORPORATION | 2002-05-07 | — | — | US | disclosed |
| EP-1181329-A1 | SILICONE GEL CONTAINING SALICYLIC ACID | NEUTROGENA CORPORATION (US) | 2002-02-27 | — | — | EP | disclosed |
| US-20010018432-A1 | Silicone gel containing salicylic acid | JOHNSON & JOHNSON CONSUMER INC. | 2001-08-30 | — | — | US | disclosed |
| WO-2001054653-A1 | GALENIC FORMULATION | MERCK PATENT GMBH (DE) | 2001-08-02 | — | — | WO | disclosed |
| US-6200964-B1 | FOR PREVENTION AND TREATMENT OF ACNE OR SEBORRHEA | NEUTROGENA CORPORATION | 2001-03-13 | — | — | US | disclosed |
| WO-2000073374-A1 | SILICONE GEL CONTAINING SALICYLIC ACID | NEUTROGENA CORPORATION (US) | 2000-12-07 | — | — | WO | disclosed |
| WO-2000072817-A1 | WATER-IN-OIL EMULSION COMPRISING A SILICONE GEL CONTAINING VITAMIN C | NEUTROGENA CORPORATION (US) | 2000-12-07 | — | — | WO | disclosed |